News Releases | Olink Holding AB

Date	Title
Sep 20, 2022	Discovery Life Sciences partners with Olink to support proteomics research and accelerate precision medicine programs
Sep 15, 2022	Multi-omics service provider Sequanta completes extended concordance validation of Olink® Target 48/96 and Olink® Explore
Aug 31, 2022	Olink strengthens management team for continued leadership in the modern proteomics era
Aug 30, 2022	Olink to participate in September investor conferences
Aug 11, 2022	Olink reports second quarter 2022 financial results
Jul 14, 2022	Olink to report second quarter 2022 financial results on August 11, 2022
Jun 28, 2022	Release of Olink® Analyze 3.1 streamlines proteomic analysis to connect data to biological insight
Jun 21, 2022	UK Biobank Pharma Proteomics Project publishes early results from its pioneering proteomics research
Jun 16, 2022	Erasmus Medical Center, Rotterdam is partnering with Olink to deepen understanding of disease progression and accelerate the development of novel therapies
Jun 13, 2022	FinnGen selects Olink to accelerate leading Population Health Study
Jun 08, 2022	Ultima Genomics and Olink collaborate to develop solution for high-throughput proteomics
Jun 07, 2022	Element Biosciences and Olink collaborate to enable Olink® Explore on the Element AVITI™ System
Jun 07, 2022	Singular Genomics and Olink collaborate to enable Olink® Explore on the G4 Max Read™ sequencing kits
Jun 02, 2022	Pharma Foods International and Olink initiate strategic partnership in Japan
Jun 01, 2022	Olink to participate in the 43rd Annual Goldman Sachs Global Healthcare Conference
May 12, 2022	Olink reports first quarter 2022 financial results
May 09, 2022	University of Oxford adopts Olink technology to advance protein biomarker discovery and unravel mechanisms of disease
Apr 21, 2022	Olink to report first quarter 2022 financial results on May 12, 2022
Apr 07, 2022	Report from the Annual General Meeting of Olink Holding AB (publ) on 7 April 2022
Mar 17, 2022	Olink publishes 2021 annual report